Table 1

Comparison of pharmacological properties of nAChR ligand binding in membrane homogenates from KXα3β4R2 cell and rat forebrain

DrugKXα3β4R2 cellRat forebrainRatio (Ki for KXα3β4R2/Ki for rat forebrain)
KinHKinH
nm nm
(±)-Epibatidine0.38  ± 0.070.99  ± 0.090.053  ± 0.0020.96  ± 0.017
(+)-Anatoxin-A52.9  ± 4.20.99  ± 0.036.51  ± 0.530.92  ± 0.048
A8538073.6  ± 6.30.88  ± 0.070.097  ± 0.0230.96  ± 0.10759
Cytisine195  ± 140.85  ± 0.021.03  ± 0.140.75  ± 0.05189
(−)-Nicotine475  ± 520.89  ± 0.087.22  ± 1.230.82  ± 0.0766
Acetylcholine881  ± 1540.82  ± 0.0832.8  ± 10.50.84  ± 0.0327
Carbachol3,839  ± 2760.83  ± 0.05428  ± 570.84  ± 0.079
d-Tubocurarine22,929  ± 3,8000.79  ± 0.061-a 2,237  ± 1,0110.63  ± 0.021-b 10
DHβE218,622  ± 32,7341.09  ± 0.0828.9  ± 15.20.62  ± 0.021-b 7,565
Hexamethonium>1,000,000102,864  ± 7,6320.85  ± 0.02
Mecamylamine>1,000,000>1,000,000

Competition binding experiments were carried out as described in Experimental Procedures using ≈500 pm [3H]EB. Hill coefficients (n H) and IC50 values (not shown) of competition binding curves were estimated by Hill plot. The inhibition constants (K i) were calculated according to the Cheng-Prusoff equation (1973). The K d values of [3H]EB used in the calculation were 300 pm for KXα3β4R2 cells and 50 pm for rat forebrain. Values shown are the mean ± standard error of three to five independent measurements.

    • 1-a n H significantly different from 1 (p < 0.05).

    • 1-b n H significantly different from 1 (p < 0.001).